Join the Oncology Voice Network. Join for Free
The Power of Storytelling in Oncology

The Power of Storytelling in Oncology


Share This Article


Why are the most powerful stories in cancer care so hard to find—and even harder to share? On this episode of the Oncology Voice Network podcast, Dr. Kirk Shepard connects with Robert Tuchman, co-founder of Amaze Media Labs and passionate healthcare advocate, to decode the art and science of storytelling in oncology. Learn why content alone isn’t enough. True impact comes from fostering genuine connections that help patients, clinicians, and innovators communicate what matters most. Robert Tuchman shares personal stories from his lifelong work with ALS and blood cancer charities, revealing why oncology’s “heavy stuff” demands courage and what happens when experts finally make their message human and accessible. From overcoming the silence around cancer to building platforms that unite scattered voices, you’ll get actionable advice on how anyone in healthcare can start sharing stories that heal, inspire, and accelerate change. Listen now and be a part of the voice that moves medicine forward.

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
OVN Avatar Charles L. Bennett , Sumimasa Nagai , Andrew C. Bennett , Shamia Hoque , Chadi Nabhan , Martin W. Schoen , William J. Hrushesky , Stefano Luminari , Paul Ray , Paul R. Yarnold , Bart Witherspoon , Josh Riente , Laura Bobolts , John Brusk , Rebecca Tombles

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

Article
External control arms in oncology: current use and future directions
OVN Avatar P.S. Mishra-Kalyani, L. Amiri Kordestani, D.R. Rivera, H. Singh, A. Ibrahim, R.A. DeClaro, Y. Shen, S. Tang, R. Sridhara, P.G. Kluetz, J. Concato, R. Pazdur, J.A. Beaver

External control arms in oncology: current use and future directions

Article
Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology
OVN Avatar Yan Ji, Jin Y. Jin, David M. Hyman, Geoffrey Kim and Ajit Suri

Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology

Article
Large pharma companies reduced headcounts by more than 22K in 2025 as $300B patent cliff looms
OVN Avatar Angus Liu

Large pharma companies reduced headcounts by more than 22K in 2025 as $300B patent cliff looms

Article
Where Did My Interview Go Wrong?
Partner Avatar Tom Caravela

Where Did My Interview Go Wrong?

Article
Loose Regulatory Standards Portend a New Era of Imprecision Oncology
OVN Avatar Ali Raza Khaki

Loose Regulatory Standards Portend a New Era of Imprecision Oncology

Explore OVN